NEJM:血栓性血小板减少性紫癜-病例报道

2019-04-18 xing.T 网络

该患者立即开始血浆交换以治疗疑似血栓性血小板减少性紫癜。如果没有及时开始治疗,血栓性血小板减少性紫癜的死亡率很高。患者接受血浆置换并接受静脉注射甲基强的松龙5天,症状消失,血小板计数增加。

患者为一名35岁的男子,因腹痛、头痛和褐色尿2天而到急诊就诊。

体检时,体温为37.5°C。保持警惕,注重时间、地点和自我感觉,没有紫癜或瘀点。实验室检查显示血红蛋白水平为8.6g/dl(正常范围为13.7至17.5),血小板计数为每立方毫米6000个(正常范围为140000至370000)。间接胆红素和乳酸脱氢酶水平升高,触珠蛋白检测不到,血清肌酐水平为1mg/dl(88umol/l;正常范围为0.6至1.3mg/dl[57至115umol/l])。人类免疫缺陷病毒感染的检查结果为阴性。外周血涂片显示许多裂片细胞(如箭头所示)。这些发现与微血管病性溶血性贫血一致。



该患者立即开始血浆交换以治疗疑似血栓性血小板减少性紫癜。如果没有及时开始治疗,血栓性血小板减少性紫癜的死亡率很高。患者接受血浆置换并接受静脉注射甲基强的松龙5天,症状消失,血小板计数增加。

治疗开始后2天确诊,ADAMTS13活性为1%。他出院后糖皮质激素治疗逐渐减量。出院三个月后,该患者保持良好状态。
 
原始出处:

Shruti Bhandari,et al.Thrombotic Thrombocytopenic Purpura.N Engl J Med 2019;https://www.nejm.org/doi/full/10.1056/NEJMicm1813768

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2065992, encodeId=9842206599224, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89016, encryptionId=9eac8901654, topicName=血小板减少性紫癜)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Jr8S1dfvNyP22t32IFDXJXnpd5AGlDibiajL5cl3pxj7OPCeAeibLhzOmZn5Q2Oicc6uKOCnxGNOggdLtI3hIW7huQ/132, createdBy=66e52500008, createdName=Tamikia, createdTime=Fri Mar 20 15:54:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078174, encodeId=429420e81742c, content=<a href='/topic/show?id=53cb89101eb' target=_blank style='color:#2F92EE;'>#血栓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89101, encryptionId=53cb89101eb, topicName=血栓性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Apr 27 22:54:00 CST 2019, time=2019-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302821, encodeId=5083130282141, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89015, encryptionId=9c72890153c, topicName=血小板减少)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Fri Apr 19 22:54:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486704, encodeId=dbf71486e0416, content=<a href='/topic/show?id=9f16e70667f' target=_blank style='color:#2F92EE;'>#紫癜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77066, encryptionId=9f16e70667f, topicName=紫癜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ea98200085, createdName=bluefate124, createdTime=Fri Apr 19 22:54:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585029, encodeId=55ce1585029e2, content=<a href='/topic/show?id=05bd8910e67' target=_blank style='color:#2F92EE;'>#血栓性血小板减少性紫癜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89107, encryptionId=05bd8910e67, topicName=血栓性血小板减少性紫癜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d517104133, createdName=xxxx1055, createdTime=Fri Apr 19 22:54:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034789, encodeId=f83e1034e8987, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 18 10:54:00 CST 2019, time=2019-04-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2065992, encodeId=9842206599224, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89016, encryptionId=9eac8901654, topicName=血小板减少性紫癜)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Jr8S1dfvNyP22t32IFDXJXnpd5AGlDibiajL5cl3pxj7OPCeAeibLhzOmZn5Q2Oicc6uKOCnxGNOggdLtI3hIW7huQ/132, createdBy=66e52500008, createdName=Tamikia, createdTime=Fri Mar 20 15:54:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078174, encodeId=429420e81742c, content=<a href='/topic/show?id=53cb89101eb' target=_blank style='color:#2F92EE;'>#血栓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89101, encryptionId=53cb89101eb, topicName=血栓性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Apr 27 22:54:00 CST 2019, time=2019-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302821, encodeId=5083130282141, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89015, encryptionId=9c72890153c, topicName=血小板减少)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Fri Apr 19 22:54:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486704, encodeId=dbf71486e0416, content=<a href='/topic/show?id=9f16e70667f' target=_blank style='color:#2F92EE;'>#紫癜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77066, encryptionId=9f16e70667f, topicName=紫癜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ea98200085, createdName=bluefate124, createdTime=Fri Apr 19 22:54:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585029, encodeId=55ce1585029e2, content=<a href='/topic/show?id=05bd8910e67' target=_blank style='color:#2F92EE;'>#血栓性血小板减少性紫癜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89107, encryptionId=05bd8910e67, topicName=血栓性血小板减少性紫癜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d517104133, createdName=xxxx1055, createdTime=Fri Apr 19 22:54:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034789, encodeId=f83e1034e8987, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 18 10:54:00 CST 2019, time=2019-04-18, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2065992, encodeId=9842206599224, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89016, encryptionId=9eac8901654, topicName=血小板减少性紫癜)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Jr8S1dfvNyP22t32IFDXJXnpd5AGlDibiajL5cl3pxj7OPCeAeibLhzOmZn5Q2Oicc6uKOCnxGNOggdLtI3hIW7huQ/132, createdBy=66e52500008, createdName=Tamikia, createdTime=Fri Mar 20 15:54:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078174, encodeId=429420e81742c, content=<a href='/topic/show?id=53cb89101eb' target=_blank style='color:#2F92EE;'>#血栓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89101, encryptionId=53cb89101eb, topicName=血栓性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Apr 27 22:54:00 CST 2019, time=2019-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302821, encodeId=5083130282141, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89015, encryptionId=9c72890153c, topicName=血小板减少)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Fri Apr 19 22:54:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486704, encodeId=dbf71486e0416, content=<a href='/topic/show?id=9f16e70667f' target=_blank style='color:#2F92EE;'>#紫癜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77066, encryptionId=9f16e70667f, topicName=紫癜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ea98200085, createdName=bluefate124, createdTime=Fri Apr 19 22:54:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585029, encodeId=55ce1585029e2, content=<a href='/topic/show?id=05bd8910e67' target=_blank style='color:#2F92EE;'>#血栓性血小板减少性紫癜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89107, encryptionId=05bd8910e67, topicName=血栓性血小板减少性紫癜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d517104133, createdName=xxxx1055, createdTime=Fri Apr 19 22:54:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034789, encodeId=f83e1034e8987, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 18 10:54:00 CST 2019, time=2019-04-18, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2065992, encodeId=9842206599224, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89016, encryptionId=9eac8901654, topicName=血小板减少性紫癜)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Jr8S1dfvNyP22t32IFDXJXnpd5AGlDibiajL5cl3pxj7OPCeAeibLhzOmZn5Q2Oicc6uKOCnxGNOggdLtI3hIW7huQ/132, createdBy=66e52500008, createdName=Tamikia, createdTime=Fri Mar 20 15:54:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078174, encodeId=429420e81742c, content=<a href='/topic/show?id=53cb89101eb' target=_blank style='color:#2F92EE;'>#血栓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89101, encryptionId=53cb89101eb, topicName=血栓性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Apr 27 22:54:00 CST 2019, time=2019-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302821, encodeId=5083130282141, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89015, encryptionId=9c72890153c, topicName=血小板减少)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Fri Apr 19 22:54:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486704, encodeId=dbf71486e0416, content=<a href='/topic/show?id=9f16e70667f' target=_blank style='color:#2F92EE;'>#紫癜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77066, encryptionId=9f16e70667f, topicName=紫癜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ea98200085, createdName=bluefate124, createdTime=Fri Apr 19 22:54:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585029, encodeId=55ce1585029e2, content=<a href='/topic/show?id=05bd8910e67' target=_blank style='color:#2F92EE;'>#血栓性血小板减少性紫癜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89107, encryptionId=05bd8910e67, topicName=血栓性血小板减少性紫癜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d517104133, createdName=xxxx1055, createdTime=Fri Apr 19 22:54:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034789, encodeId=f83e1034e8987, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 18 10:54:00 CST 2019, time=2019-04-18, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2065992, encodeId=9842206599224, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89016, encryptionId=9eac8901654, topicName=血小板减少性紫癜)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Jr8S1dfvNyP22t32IFDXJXnpd5AGlDibiajL5cl3pxj7OPCeAeibLhzOmZn5Q2Oicc6uKOCnxGNOggdLtI3hIW7huQ/132, createdBy=66e52500008, createdName=Tamikia, createdTime=Fri Mar 20 15:54:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078174, encodeId=429420e81742c, content=<a href='/topic/show?id=53cb89101eb' target=_blank style='color:#2F92EE;'>#血栓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89101, encryptionId=53cb89101eb, topicName=血栓性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Apr 27 22:54:00 CST 2019, time=2019-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302821, encodeId=5083130282141, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89015, encryptionId=9c72890153c, topicName=血小板减少)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Fri Apr 19 22:54:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486704, encodeId=dbf71486e0416, content=<a href='/topic/show?id=9f16e70667f' target=_blank style='color:#2F92EE;'>#紫癜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77066, encryptionId=9f16e70667f, topicName=紫癜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ea98200085, createdName=bluefate124, createdTime=Fri Apr 19 22:54:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585029, encodeId=55ce1585029e2, content=<a href='/topic/show?id=05bd8910e67' target=_blank style='color:#2F92EE;'>#血栓性血小板减少性紫癜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89107, encryptionId=05bd8910e67, topicName=血栓性血小板减少性紫癜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d517104133, createdName=xxxx1055, createdTime=Fri Apr 19 22:54:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034789, encodeId=f83e1034e8987, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 18 10:54:00 CST 2019, time=2019-04-18, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2065992, encodeId=9842206599224, content=<a href='/topic/show?id=9eac8901654' target=_blank style='color:#2F92EE;'>#血小板减少性紫癜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89016, encryptionId=9eac8901654, topicName=血小板减少性紫癜)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Jr8S1dfvNyP22t32IFDXJXnpd5AGlDibiajL5cl3pxj7OPCeAeibLhzOmZn5Q2Oicc6uKOCnxGNOggdLtI3hIW7huQ/132, createdBy=66e52500008, createdName=Tamikia, createdTime=Fri Mar 20 15:54:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078174, encodeId=429420e81742c, content=<a href='/topic/show?id=53cb89101eb' target=_blank style='color:#2F92EE;'>#血栓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89101, encryptionId=53cb89101eb, topicName=血栓性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Apr 27 22:54:00 CST 2019, time=2019-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302821, encodeId=5083130282141, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89015, encryptionId=9c72890153c, topicName=血小板减少)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e07307, createdName=lingaifan, createdTime=Fri Apr 19 22:54:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486704, encodeId=dbf71486e0416, content=<a href='/topic/show?id=9f16e70667f' target=_blank style='color:#2F92EE;'>#紫癜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77066, encryptionId=9f16e70667f, topicName=紫癜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ea98200085, createdName=bluefate124, createdTime=Fri Apr 19 22:54:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585029, encodeId=55ce1585029e2, content=<a href='/topic/show?id=05bd8910e67' target=_blank style='color:#2F92EE;'>#血栓性血小板减少性紫癜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89107, encryptionId=05bd8910e67, topicName=血栓性血小板减少性紫癜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d517104133, createdName=xxxx1055, createdTime=Fri Apr 19 22:54:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034789, encodeId=f83e1034e8987, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 18 10:54:00 CST 2019, time=2019-04-18, status=1, ipAttribution=)]
    2019-04-18 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

相关资讯

Neurology:降主动脉血栓逆行脑栓塞

65岁,女性,因突发完全失语和右侧偏瘫(NIHSS 22分)1h55min就诊。

BMJ:内源性睾酮含量与血栓、心力衰竭以及心肌梗塞风险

研究发现,内源性睾酮含量与男性血栓、心力衰竭以及心肌梗塞呈正相关

Sci Tran Med:"改良版"血小板可对抗血栓、肿瘤

科学家们“改良”了血小板,制成血小板诱饵(platelet decoys),可有效预防血栓的形成,并可能预防癌症转移。

颅内动脉瘤主瘤腔血栓形成载子囊破裂1例

女,52岁,因突发头痛3 h入院。术前Hunt-Hess分级2级。急诊头颅CT示:鞍上池及右侧环池积血、广泛蛛网膜下腔出血、右额叶血肿(图1A、1B)。发病后10 h头颅CTA检查未见确切动脉瘤征象(图1C)。发病24 h 2D-DSA检查发现右侧胼缘动脉额中内侧分支一微小动脉瘤,大小约1 mm×1.5 mm,余血管造影均未见异常(图1D)。因条件限制未行3D-DSA及旋转重建。

Lancet:血栓直接抽吸与切除用于大血管闭塞型脑卒中患者

研究认为,大血管闭塞型脑卒中患者接受血栓直接抽吸的效果与切除相当

Stroke:串联病变者,颅外颈动脉是否应该紧急支架置入?

对于急性缺血性卒中,颅外颈动脉并串联颅内大动脉闭塞者预后不良。在不同血管内血栓切除术的随机试验中,串联病变的管理方法差异较大,有些把颅外颈动脉闭塞排除在试验以外,比如SWIFT PRIME 和 EXTEND IA 试验。在 MR CLEAN 试验(32.3%)、REVASCAT 试验(18.6%)和 ESCAPE 试验(17%)中,串联病变占的比例很高。尽管占比很高以及不治疗者预后